David Windley
Stock Analyst at Jefferies
(4.52)
# 301
Out of 4,761 analysts
187
Total ratings
66.67%
Success rate
13.88%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CNC Centene | Downgrades: Underperform | $68 → $52 | $57.68 | -9.85% | 26 | Dec 10, 2024 | |
| OSCR Oscar Health | Initiates: Underperform | $12 | $14.82 | -19.03% | 1 | Dec 10, 2024 | |
| HUM Humana | Downgrades: Hold | $419 → $253 | $255.91 | -1.14% | 18 | Oct 7, 2024 | |
| FTRE Fortrea Holdings | Downgrades: Hold | $25 → $21 | $14.88 | +41.13% | 2 | Sep 25, 2024 | |
| MEDP Medpace Holdings | Downgrades: Hold | $415 → $345 | $340.22 | +1.40% | 5 | Sep 25, 2024 | |
| CI The Cigna Group | Maintains: Buy | $402 → $422 | $299.81 | +40.76% | 17 | Sep 17, 2024 | |
| MOH Molina Healthcare | Maintains: Hold | $354 → $297 | $283.81 | +4.65% | 23 | Jul 24, 2024 | |
| IQV IQVIA Holdings | Downgrades: Hold | $266 → $242 | $191.04 | +26.68% | 4 | Jul 24, 2024 | |
| UNH UnitedHealth Group | Upgrades: Buy | $481 → $647 | $466.42 | +38.72% | 26 | Jul 17, 2024 | |
| NOTV Inotiv | Downgrades: Hold | $12 → $3.75 | $4.06 | -7.64% | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $602 → $604 | $385.10 | +56.84% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $365 → $375 | $591.79 | -36.63% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $16 | $13.52 | +14.64% | 3 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $270 | $225.79 | +19.58% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $16 | $13.17 | +17.69% | 3 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $323 → $536 | $210.91 | +154.14% | 10 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $39 → $29 | $20.90 | +38.76% | 2 | Nov 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $233 → $203 | $163.02 | +24.52% | 19 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $276 → $302 | $201.39 | +49.96% | 14 | Sep 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $264 → $248 | $11.51 | +2,054.65% | 1 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.64 | - | 5 | Oct 9, 2017 |
Centene
Dec 10, 2024
Downgrades: Underperform
Price Target: $68 → $52
Current: $57.68
Upside: -9.85%
Oscar Health
Dec 10, 2024
Initiates: Underperform
Price Target: $12
Current: $14.82
Upside: -19.03%
Humana
Oct 7, 2024
Downgrades: Hold
Price Target: $419 → $253
Current: $255.91
Upside: -1.14%
Fortrea Holdings
Sep 25, 2024
Downgrades: Hold
Price Target: $25 → $21
Current: $14.88
Upside: +41.13%
Medpace Holdings
Sep 25, 2024
Downgrades: Hold
Price Target: $415 → $345
Current: $340.22
Upside: +1.40%
The Cigna Group
Sep 17, 2024
Maintains: Buy
Price Target: $402 → $422
Current: $299.81
Upside: +40.76%
Molina Healthcare
Jul 24, 2024
Maintains: Hold
Price Target: $354 → $297
Current: $283.81
Upside: +4.65%
IQVIA Holdings
Jul 24, 2024
Downgrades: Hold
Price Target: $266 → $242
Current: $191.04
Upside: +26.68%
UnitedHealth Group
Jul 17, 2024
Upgrades: Buy
Price Target: $481 → $647
Current: $466.42
Upside: +38.72%
Inotiv
May 14, 2024
Downgrades: Hold
Price Target: $12 → $3.75
Current: $4.06
Upside: -7.64%
Apr 19, 2024
Maintains: Buy
Price Target: $602 → $604
Current: $385.10
Upside: +56.84%
Apr 19, 2024
Maintains: Hold
Price Target: $365 → $375
Current: $591.79
Upside: -36.63%
Mar 25, 2024
Upgrades: Buy
Price Target: $15 → $16
Current: $13.52
Upside: +14.64%
Mar 4, 2024
Maintains: Buy
Price Target: $225 → $270
Current: $225.79
Upside: +19.58%
Mar 1, 2024
Maintains: Hold
Price Target: $14 → $16
Current: $13.17
Upside: +17.69%
Feb 7, 2024
Upgrades: Buy
Price Target: $323 → $536
Current: $210.91
Upside: +154.14%
Nov 1, 2023
Downgrades: Hold
Price Target: $39 → $29
Current: $20.90
Upside: +38.76%
Mar 28, 2023
Maintains: Hold
Price Target: $233 → $203
Current: $163.02
Upside: +24.52%
Sep 14, 2021
Maintains: Buy
Price Target: $276 → $302
Current: $201.39
Upside: +49.96%
Feb 25, 2021
Maintains: Hold
Price Target: $264 → $248
Current: $11.51
Upside: +2,054.65%
Oct 9, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.64
Upside: -